Researchers published Superb-seq, a single-cell platform intended to read out both on-target and off-target Cas9 edits alongside transcriptome changes in individual cells. Developed by Salk scientists and collaborators, the approach integrates Cas9 editing, T7 transcription, and single-cell RNA sequencing to detect edit locations and quantify downstream gene expression consequences. In testing across multiple cell lines, Superb-seq identified edit sites including off-target events that can be invisible to conventional detection approaches. The team also reported improved interpretation versus Perturb-seq because Superb-seq adds edit readout rather than inferring editing solely from perturbation readouts. For the CRISPR toolchain, the platform’s utility could extend to safer therapeutic development where off-target profiles must be tied to cellular functional outcomes, not just DNA changes.
Get the Daily Brief